Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Insulin-like growth factor receptor and sphingosine kinase are prognostic and therapeutic targets in breast cancer

BMC Cancer201717:820

https://doi.org/10.1186/s12885-017-3809-0

Received: 3 August 2017

Accepted: 21 November 2017

Published: 5 December 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
3 Aug 2017 Submitted Original manuscript
13 Aug 2017 Author responded Author comments - Aleksandra Ochnik
Resubmission - Version 2
13 Aug 2017 Submitted Manuscript version 2
3 Sep 2017 Reviewed Reviewer Report - Adrian Lee
23 Sep 2017 Reviewed Reviewer Report - Teresa Wood
19 Oct 2017 Author responded Author comments - Aleksandra Ochnik
Resubmission - Version 3
19 Oct 2017 Submitted Manuscript version 3
4 Nov 2017 Reviewed Reviewer Report - Adrian Lee
5 Nov 2017 Reviewed Reviewer Report - Teresa Wood
15 Nov 2017 Author responded Author comments - Aleksandra Ochnik
Resubmission - Version 4
15 Nov 2017 Submitted Manuscript version 4
Publishing
21 Nov 2017 Editorially accepted
5 Dec 2017 Article published 10.1186/s12885-017-3809-0

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Kolling Institute, University of Sydney, Royal North Shore Hospital
(2)
Centre for Drug Discovery & Development, Sansom Institute for Health Research, School of Pharmacy & Medical Sciences, University of South Australia

Advertisement